DR. SCOTT MACKAY MORCOTT M.D.
Prescription History 1386638708
Family Medicine in Lake Bluff, IL

NPI Status: Active since August 31, 2005

Contact Information

10 E SCRANTON AVE STE 303
LAKE BLUFF, IL
ZIP 60044
Phone: (847) 816-3434
Fax: (847) 686-7284

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SCOTT MACKAY MORCOTT M.D., an active Family Medicine specialist practicing in Lake Bluff, IL. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 418 documented patient claims. Among these therapy options, the most frequently utilized medication is Typhim Vi, which accounts for 138 claims alone.

Medication Index

No matching medications currently found on file.

Adacel Tdap

Generic Formulation: Diph,pertuss(Acell),tet Vac/PfSpecialty: Family Practice
Provider Metrics Summary
Total Claims 62
30-Day Fills 62.0
Days Supply 178
IL State Average Benchmarks
Peer Average Claims57.0
Peer Average 30-Day Fills58.0
Peer Average Days Supply107
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,303.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$85.54

State Avg Cost Per Claim

$68.35

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This vaccine is used to keep up protection (immunity) against diphtheria, tetanus (lockjaw) and pertussis (whooping cough) in children and adults who have been vaccinated for these diseases in the past. It may also be given during the third trimester of pregnancy to help prevent pertussis in the newborn baby. Vaccination is the best way to protect against these life-threatening diseases. Vaccines work by causing the body to produce its own protection (antibodies). Booster doses are needed to keep up immunity because antibody levels may become too low over time to provide the needed protection.

Ipol

Generic Formulation: Poliomyelitis Vaccine, KilledSpecialty: Family Practice
Provider Metrics Summary
Total Claims 35
30-Day Fills 35.0
Days Supply 93
IL State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills35.0
Peer Average Days Supply93
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,589.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$73.97

State Avg Cost Per Claim

$61.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Menquadfi

Generic Formulation: Mening Vac A,c,y,w135,c-Tet/PfSpecialty: Family Practice
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 14
IL State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills16.0
Peer Average Days Supply16
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,778.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$127.00

State Avg Cost Per Claim

$175.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Twinrix

Generic Formulation: Hepatitis A And B Vaccine/PfSpecialty: Family Practice
Provider Metrics Summary
Total Claims 73
30-Day Fills 73.0
Days Supply 189
IL State Average Benchmarks
Peer Average Claims177.0
Peer Average 30-Day Fills177.2
Peer Average Days Supply204
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.8% less volume than the regional standard for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,958.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$163.81

State Avg Cost Per Claim

$141.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Typhim Vi

Generic Formulation: Typhoid Vi Polysacch VaccineSpecialty: Family Practice
Provider Metrics Summary
Total Claims 138
30-Day Fills 138.0
Days Supply 486
IL State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills38.2
Peer Average Days Supply80
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 273.0% higher than the standard regional baseline profile for IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $17,292.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$125.30

State Avg Cost Per Claim

$134.46

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Vaqta

Generic Formulation: Hepatitis A Virus Vaccine/PfSpecialty: Family Practice
Provider Metrics Summary
Total Claims 35
30-Day Fills 35.0
Days Supply 180
IL State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills31.0
Peer Average Days Supply50
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,232.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$120.92

State Avg Cost Per Claim

$95.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).

Therapeutic Applications

This vaccine is used to help prevent infection from the hepatitis A virus. Hepatitis A infection can be mild with no symptoms or a severe illness that can rarely cause liver failure and death. Preventing infection can prevent these problems. Hepatitis A vaccine is made from whole, killed hepatitis A virus. It does not contain live virus, so you cannot get hepatitis from the vaccine. This vaccine works by helping the body produce immunity (through antibody production) that will prevent you from getting infection from hepatitis A virus. Hepatitis A vaccine does not protect you from other virus infections (such as HIV virus, which causes AIDS; hepatitis B, hepatitis C or hepatitis E; HPV virus, which causes genital warts and other problems). The vaccine is recommended for people aged 12 months and older, especially those at an increased risk of getting the infection. Those at an increased risk include people who live with or spend much time with people with hepatitis A infections, institutional or daycare workers, lab workers, people with multiple sex partners, men who have sex with men, sex workers, injecting and non-injecting drug abusers, and people traveling to high-risk areas.

Yf-Vax

Generic Formulation: Yellow Fever Vaccine Live/PfSpecialty: Family Practice
Provider Metrics Summary
Total Claims 61
30-Day Fills 61.0
Days Supply 177
IL State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills13.5
Peer Average Days Supply13
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 369.2% higher than the standard regional baseline profile for IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,229.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$167.69

State Avg Cost Per Claim

$207.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. SCOTT MACKAY MORCOTT M.D. provides transparency into local medical care patterns within Lake Bluff, IL.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Family Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.